Tetanus Vaccine | Shim Clinic, Singapore

Tetanus Vaccine | Shim Clinic, Singapore: Tetanus vaccine jab/shot/injection, to vaccinate against Clostridium tetani, to immunise against tetanus clinic, Singapore. Private and confidential service. Definitions, references, and latest news.

Description

Vaccine types available for vaccination:

Vaccine	Against	Disease	Age	D o s e s	Dose schedule	Price per dose (SG$)
Fluarix™ Influenza vaccine	Influenza virus	Influenza	6-36m	½	1 yearly	$30/=
			>3y	1
Typhim Vi Typhoid vaccine	Salmonella typhi	Typhoid fever	>5y	1	3 yearly	$40/=
Tetavax Tetanus vaccine	Clostridium tetani	Tetanus	adults	3	1-2m interval 3rd @ 6-12m after 2nd	$20/=
			booster	1	10 yearly
Varilrix™ - Chickenpox vaccine - Varicella vaccine - Shingles vaccine - Herpes zoster vaccine	Varicella zoster virus	Chickenpox Herpes zoster	12m-12y	1		$121/=
			≥13y	2	6-10w interval
Mencevax® ACWY - Meningococcal vaccine - Meningitis vaccine	Neisseria meningitidis types A, C, W-135 and Y	Meningococcal meningitis	>2y	1		$76/=
Pneumovax® 23 - Pneumococcal polysaccharide vaccine - Pneumococcal vaccine	Streptococcus pneumoniae types 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 19A, 20, 22F, 23F and 33F	Pneumococcal infection	≥50y	1		$99/=
Prevenar 13® - Pneumococcal conjugate vaccine - Pneumococcal vaccine	Streptococcus pneumoniae types 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F	Pneumococcal infection	6w-6m	4	1m interval 4th @ 12-15m	$274/=
			7-11m	2	1m interval
			12-23m	2	2m interval
			2-5y	1
			≥50y	1
MMR vaccine			≥12m	1		$70/=
- Measles vaccine	Measles virus	Measles
- Mumps vaccine	Mumps virus	Mumps
- Rubella vaccine	Rubella virus	Rubella
Boostrix® - DPT vaccine - DTP vaccine			≥4y	1	<10 yearly	$70/=
- Diphtheria vaccine	Corynebacterium diphtheriae	Diphtheria
- Tetanus vaccine	Clostridium tetani	Tetanus
- Pertussis vaccine - Whooping cough vaccine	Bordetella pertussis	Pertussis Whooping cough

Meningococcal vaccine is recommended for persons traveling to sub-Saharan Africa, especially during the dry season (December to June), to other areas of current or recent epidemic activity, and to Mecca at any time. Particularly for the Hajj/Haj and Umrah.

If the clinic attendance is just for vaccination alone, no additional consultation fees are charged.

STD vaccine / hepatitis vaccine shot/jab/injection to prevent some STDs

Vaccine	Against	Disease	Age	D o s e s	Dose schedule	Price per dose (SG$)
Havrix™ 1440 Adult Hepatitis A vaccine	Hepatitis A virus	Hepatitis A	≥19y	2	m 0 & 6-12	$90/=
Engerix™-B 20 μg Hepatitis B vaccine	Hepatitis B virus	Hepatitis B	11-15y	2	m 0, & 6	$50/=
			≥20y	3	m 0, 1, & 6
				4	m 0, 1, 2, & 12 or d 0, 7, 21 & m 12
Twinrix®	Hepatitis A virus Hepatitis B virus	Hepatitis A Hepatitis B	1-15y	2	m 0, 6-12	$120/=
			≥16y	3	m 0, 1, 6
				4	d 0, 7, 21 & m 12
Gardasil® - HPV vaccine	HPV types 6, 11, 16 and 18	Genital warts Cervical cancer	9-26y	3	m 0, 2, & 6 or m 0, 1, & 4	$195/=
Cervarix® - HPV vaccine	HPV types 16 and 18 (31, 33, and 45)	Genital warts Cervical cancer	10-25y	3	m 0, 1, & 6 m 0, 1, & 5 m 0, 2½, 12	$195/=
V503 - HPV vaccine	HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58	Genital warts Cervical cancer		3	m 0, 2, & 6 or m 0, 1, & 4	$???/=

References

• Tetanus vaccine - Wikipedia, the free encyclopedia
• Tetanus vaccine: Definition from Answers.com
• Tetanus vaccine - definition of Tetanus vaccine in the Medical dictionary - by the Free Online Medical Dictionary, Thesaurus and Encyclopedia.

Clinician awareness of tetanus-diphtheria vaccination in trauma patients: a questionnaire study
Tue, 15 May 2012 04:00:00 +0100 | Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
Conclusion: Attitude changes should be encouraged among emergency physicians regarding tetanus prophylaxis. As emergency physicians are frequently confronted with patients that are at a high risk for tetanus infection in emergency situations, they need to be more informed regarding tetanus immunity epidemiology and encouraged to administer tetanus booster vaccines. (Source: Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine)

Peer-reviewed junk science — debunked
Thu, 10 May 2012 04:00:00 +0100 | Health Facts and Fears
A recent prospective study published in the Journal of the American Medical Association suggested that exposure to perfluorinated compounds (PFCs) — chemicals commonly found in non-stick pans and food packaging — reduces immune responses to tetanus and diphtheria vaccinations among children aged 5 to 7 years old. (Source: Health Facts and Fears)

DTaP Vaccine Shortage Dictates Order Limits, Says Sanofi
Mon, 07 May 2012 19:20:00 +0100 | AAFP Health of the Public
Sanofi Pasteur recently began limiting monthly orders for two of its combination vaccines and likely will continue that practice through September, according to company sources. In a letter sent last month to health care professionals, Sanofi said a manufacturing delay is responsible for limiting supplies of the company's combined diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and Haemophilus influenzae (Source: AAFP Health of the Public)

Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study
Mon, 07 May 2012 04:00:00 +0100 | Annals of the Rheumatic Diseases
Conclusions Patients with JIA had lower antibody concentrations and seroprotection rates than healthy controls against mumps, rubella, diphtheria and tetanus, but not measles. In these patients, regular assessment of antibody concentrations and further research on responses to other (booster) vaccines are warranted. (Source: Annals of the Rheumatic Diseases)

Underinsurance for Recently Recommended Vaccines in Private Health Plans
Sat, 05 May 2012 06:03:10 +0100 | Journal of Community Health
Abstract  Underinsurance for vaccines presents financial barriers to vaccination. Preventive services coverage is of interest in national healthcare reform. To assess vaccine benefits coverage in private health plans. Private health insurance carriers were surveyed December 2008–June 2009 on policies regarding vaccine coverage in fully insured plans. Carriers were identified as multi-state, state-specific Blue Cross or local-independent carriers. Plan types included HMO, PPO, POS and ‘other.’ Full benefits coverage was defined as having benefits without a copay or coinsurance for a recommended vaccine. Analyses were conducted to examine associations between carrier type, plan type, and full benefits coverage. Fifty-one carriers (response rate = 56 %) pro...

Cochrane Review: Interventions for improving coverage of child immunization in low‐ and middle‐income countries
Thu, 03 May 2012 04:00:00 +0100 | Evidence-Based Child Health: A Cochrane Review Journal
AbstractBackgroundImmunization coverage remains low, particularly in low‐ and middle‐income countries (LMIC), despite its proven effectiveness in reducing the burden of childhood infectious diseases. A Cochrane review has shown that patient reminder recall is effective in improving coverage of immunization but technologies to support this strategy are lacking in LMIC.ObjectivesTo evaluate the effectiveness of intervention strategies to boost and sustain high childhood immunization coverage in LMIC.Search methodsWe searched the following databases for primary studies: Cochrane Central Register of Controlled Trials (CENTRAL) 2010, Issue 1, part of The Cochrane Library. www.thecochranelibrary.com, including the Cochrane Effective Practice and Organisation of Care (EPOC) Group Specialised ...

Does Tdap Vaccination Interfere with Serodiagnosis of Pertussis Infection?
Wed, 25 Apr 2012 04:00:00 +0100 | Clinical and Vaccine Immunology
Conclusions. Tdap vaccination six months prior to testing did not confound result interpretation. This seroassay remains a valuable diagnostic tool for adult pertussis. PMID: 22539469 [PubMed - as supplied by publisher] (Source: Clinical and Vaccine Immunology)

Induction of proapoptotic antibodies to triple‐negative breast cancer by vaccination with TRAIL death receptor DR5 DNA
Tue, 24 Apr 2012 04:00:00 +0100 | International Journal of Cancer
AbstractTNF‐related apoptosis‐inducing ligand receptor 2 [TRAIL‐R2 or death receptor 5 (DR5)] is expressed at elevated levels in a broad range of solid tumors to mediate apoptotic signals from TRAIL or agonist antibodies. We tested the hypothesis that DR5 DNA vaccination will induce proapoptotic antibody to trigger apoptosis of tumor cells. BALB/c mice were electrovaccinated with DNA‐encoding wild‐type human DR5 (phDR5) or its derivatives. Resulting immune serum or purified immune IgG induced apoptosis in triple‐negative breast cancer (TNBC) cells, which were also TRAIL sensitive. The proapoptotic activity of immune serum at dilutions of 0.5–2% was comparable to that of 1–2 μg/ml of TRAIL. Apoptotic activity of immune serum was enhanced by antibody crosslinking. Apoptotic ...

Notes From the Field: Use of Tetanus, Diphtheria, and Pertussis Vaccine (Tdap) in an Emergency Department--Arizona, 2009-2010 [From the Centers for Disease Control and Prevention]
Tue, 24 Apr 2012 04:00:00 +0100 | JAMA
(Source: JAMA)

ABOUT TRUST ONLINE